Read more from STAT & other publishers

  1. After rivals' IPOs, will CRISPR Therapeutics go public or stay buttoned-down?
    STAT
  2. Clash of scientific titans: CRISPR hits the courts, with money and prestige at stake
    STAT
  3. Genome-editing find may improve system’s precision
    STAT
  4. At 31, she runs one of the hottest biotech companies in the country
    STAT
  5. Gene-editing biotech Intellia files for $120 million IPO
    STAT

 

  1. Can Fingerprints Predict Diabetes?
    Diabetes In Control, 2016
  2. Gene Patenting Decision: One Perspective
    EMBS J Transl Eng Health Med, 2013
  3. Transcript: Dr. Aaron Vinik Discusses INGAP Research
    Diabetes In Control, 2016
  4. <!--846 guest article-->Beta Bionics Reaches a Milestone
    Diabetes In Control, 2016
  5. New British PM is Type 1
    Diabetes In Control, 2016
Powered by